Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

OTSSP167 (hydrochloride)

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.

Product Specifications

CAS Number

[1431698-10-0]

Product Name Alternative

OTS167 (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

MELK

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/OTSSP167-hydrochloride.html

Purity

99.78

Solubility

DMSO : 33.33 mg/mL (ultrasonic) |H2O : 7.14 mg/mL (ultrasonic)

Smiles

ClC1=CC(C2=CC=C(N=CC(C(C)=O)=C3N[C@H]4CC[C@H](CN(C)C)CC4)C3=N2)=CC(Cl)=C1O.[H]Cl

Molecular Formula

C25H29Cl3N4O2

Molecular Weight

523.88

Precautions

H302, H315, H319

References & Citations

[1]Chung S, Suzuki H, Miyamoto T, et al. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec 21.|[2]Ji W, et al. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases. PLoS One. 2016 Apr 15;11 (4) :e0153518.|[3]Cho YS, et al. The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor. Biochem Biophys Res Commun. 2014 Apr 25;447 (1) :7-11.|[4]Jurmeister S, et al. Identification of potential therapeutic targets in prostate cancer through a cross-species approach. EMBO Mol Med. 2018 Feb 5. pii: e8274.|[5]Meel MH, et al. MELK inhibition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res. 2018 Jul 30. pii: clincanres.0924.2018.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Citation 01

Clin Cancer Res. 2018 Nov 15;24 (22) :5645-5657. |Elife. 2017 Mar 24;6:e24179.|Elife. 2018 Feb 8;7:e32838. |EMBO Mol Med. 2018 Mar;10 (3) . pii: e8274.|Free Radic Biol Med. 2021 Aug 20:172:312-329.|Gynecol Oncol. 2017 Apr;145 (1) :159-166.|Harvard Medical School LINCS LIBRARY|Int J Mol Sci. 2025 Mar 3;26 (5) :2245.|Nat Cancer. 2024 Aug;5 (8) :1250-1266.|Neuro Oncol. 2020 Jan 11;22 (1) :58-69. |University of Washington. 2025.|Adv Ther (Weinh) . 2025 Oct 24.|Biochem Biophys Res Commun. 2014 Apr 25;447 (1) :7-11. |Blood Cancer J. 2019 Nov 18;9 (12) :87.|Eur J Pharmacol. 2025 Oct 5:1004:178017.|Int J Oncol. 2022 Jul;61 (1) :89.|Mol Cancer. 2014 May 4;13:100.|Oncotarget. 2016 Feb 2;7 (5) :6266-80. |Oncotarget. 2017 Dec 20;9 (2) :2591-2602. |Patent. US20160291017A1.|PLoS One. 2017 Feb 24;12 (2) :e0172832. |Sci Rep. 2017 Feb 14;7:42502.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CX3CL1 polyclonal antibody
BS60619-01 50 µL

CX3CL1 polyclonal antibody

Ask
View Details
CX3CL1 polyclonal antibody
BS60619-02 100 µL

CX3CL1 polyclonal antibody

Ask
View Details
SMAD1 Rabbit Polyclonal Antibody
AP08071PU-N 100 µL

SMAD1 Rabbit Polyclonal Antibody

Ask
View Details
Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit
abx490311-01 96 Tests

Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit

Ask
View Details
Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit
abx490311-02 5x 96 Tests

Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit

Ask
View Details
Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit
abx490311-03 10x 96 Tests

Human Cross Linked C-Telopeptide Of Type III Collagen (CTXIII) CLIA Kit

Ask
View Details